{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:25:57Z","timestamp":1793913957386,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2015CB554001"],"award-info":[{"award-number":["2015CB554001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372142"],"award-info":[{"award-number":["81372142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2017YFC1308800"],"award-info":[{"award-number":["2017YFC1308800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>BMP3 gene is often found hypermethylated and hence inactivated in several types of cancers including colorectal cancer (CRC), indicating that it has a suppressor role in carcinogenesis. Though BMP3 is a reliable biomarker for screening CRC, the molecular mechanism of BMP3 in carcinogenesis remains largely unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression level of BMP3 was examined by immunohistochemistry staining and western blot. Methylation-specific PCR (MSP) and real-time quantitative MSP were used to test the hypermethylation status of BMP3 gene. Analyses of BMP3 function in colon cancer cell proliferation, migration, invasion, and apoptosis were performed using HCT116 and KM12 cells. BMP3 was further knocked down or overexpressed in CRC cells, and the effects on cell growth of xenograft tumors in nude mice were assessed. Co-immunoprecipitation and immunofluorescence staining were used to analyze the association between BMP3 and BMPR2 or BMP3 and ActRIIB. Microarray analysis was performed to identify most differentially expressed genes and pathways regulated by BMP3. The BMP3-regulated SMAD2-dependent signaling pathway and TAK1\/JNK signal axes were further investigated by quantitative PCR and western blot.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BMP3 gene was hypermethylated and its expression was downregulated in both CRC tissues and cell lines. Expressing exogenous BMP3 in HCT116 inhibited cell growth, migration, and invasion and increased rate of apoptosis both in vitro and in vivo. However, shRNA-mediated attenuation of endogenous BMP3 in KM12 reversed such inhibitory and apoptotic effects. Furthermore, BMP3 could bind to ActRIIB, an activin type II receptor at the cellular membrane, thereby activating SMAD2-dependent pathway and TAK1\/JNK signal axes to regulate downstream targets including caspase-7, p21, and SMAD4 that play crucial roles in cell cycle control and apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study reveals a previously unknown mechanism of BMP3 tumor suppression in CRC and provides a rationale for future investigation of BMP3 as a potential target for the development of novel therapeutic agents to fight CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-019-1435-1","type":"journal-article","created":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T16:44:07Z","timestamp":1572453847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["BMP3 suppresses colon tumorigenesis via ActRIIB\/SMAD2-dependent and TAK1\/JNK signaling pathways"],"prefix":"10.1186","volume":"38","author":[{"given":"Jialing","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitong","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM198809013190901","volume":"9","author":"B Vogelstein","year":"1988","unstructured":"Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;9:525\u201332.","journal-title":"N Engl J Med"},{"key":"1435_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2010.06.002","volume":"1","author":"DC Snover","year":"2011","unstructured":"Snover DC. Update on the serrated pathway to colorectal carcinoma. Hum Pathol. 2011;1:1\u201310.","journal-title":"Hum Pathol"},{"key":"1435_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"1","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;1:11\u20139.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1435_CR4","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1016\/j.ajpath.2011.08.022","volume":"6","author":"Y Shirai","year":"2011","unstructured":"Shirai Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K. Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol. 2011;6:2920\u201330.","journal-title":"Am J Pathol"},{"key":"1435_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"7120","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;7120:761\u20135.","journal-title":"Nature"},{"key":"1435_CR6","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1158\/0008-5472.CAN-17-0112","volume":"15","author":"Y Yokoyama","year":"2017","unstructured":"Yokoyama Y, Watanabe T, Tamura Y, Hashizume Y, Miyazono K, Ehata S. Autocrine BMP-4 signaling is a therapeutic target in colorectal Cancer. Cancer Res. 2017;15:4026\u201338.","journal-title":"Cancer Res"},{"key":"1435_CR7","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1158\/0008-5472.CAN-10-4374","volume":"15","author":"YC Lee","year":"2011","unstructured":"Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH. BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res. 2011;15:5194\u2013203.","journal-title":"Cancer Res"},{"key":"1435_CR8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2007.08.021","volume":"4","author":"LL Kodach","year":"2007","unstructured":"Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, Hardwick JC. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Gastroenterology. 2007;4:1272\u201381.","journal-title":"Gastroenterology"},{"key":"1435_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.onc.1209110","volume":"5","author":"EM Langenfeld","year":"2006","unstructured":"Langenfeld EM, Kong Y, Langenfeld J. Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1\/5. Oncogene. 2006;5:685\u201392.","journal-title":"Oncogene"},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1038\/onc.2008.232","volume":"49","author":"Y Katsuno","year":"2008","unstructured":"Katsuno Y, Hanyu A, Kanda H, Ishikawa Y, Akiyama F, Iwase T, Ogata E, Ehata S, Miyazono K, Imamura T. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene. 2008;49:6322\u201333.","journal-title":"Oncogene"},{"key":"1435_CR11","first-page":"4427","volume":"19","author":"FC Hamdy","year":"1997","unstructured":"Hamdy FC, Autzen P, Robinson MC, Horne CH, Neal DE, Robson CN. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res. 1997;19:4427\u201331.","journal-title":"Cancer Res"},{"key":"1435_CR12","doi-asserted-by":"publisher","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-04-2251","volume":"22","author":"DR Haudenschild","year":"2004","unstructured":"Haudenschild DR, Palmer SM, Moseley TA, You Z, Reddi AH. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer. Cancer Res. 2004;22:8276\u201384.","journal-title":"Cancer Res"},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20110840","volume":"13","author":"A Kobayashi","year":"2011","unstructured":"Kobayashi A, Okuda H, Xing F, Pandey PR, Watabe M, Hirota S, Pai SK, Liu W, Fukuda K, Chambers C, et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med. 2011;13:2641\u201355.","journal-title":"J Exp Med"},{"key":"1435_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.cytogfr.2009.10.007","volume":"5\u20136","author":"C Sieber","year":"2009","unstructured":"Sieber C, Kopf J, Hiepen C, Knaus P. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 2009;5\u20136:343\u201355.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1435_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1046\/j.1365-2443.2002.00599.x","volume":"12","author":"K Miyazawa","year":"2002","unstructured":"Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 2002;12:1191\u2013204.","journal-title":"Genes Cells"},{"key":"1435_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/83810","volume":"1","author":"A Daluiski","year":"2001","unstructured":"Daluiski A, Engstrand T, Bahamonde ME, Gamer LW, Agius E, Stevenson SL, Cox K, Rosen V, Lyons KM. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet. 2001;1:84\u20138.","journal-title":"Nat Genet"},{"key":"1435_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ydbio.2005.06.012","volume":"1","author":"LW Gamer","year":"2005","unstructured":"Gamer LW, Nove J, Levin M, Rosen V. BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. Dev Biol. 2005;1:156\u201368.","journal-title":"Dev Biol"},{"key":"1435_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22064","volume":"3","author":"A Stewart","year":"2010","unstructured":"Stewart A, Guan H, Yang K. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta\/activin signaling pathway. J Cell Physiol. 2010;3:658\u201366.","journal-title":"J Cell Physiol"},{"key":"1435_CR19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0092-8674(91)90549-E","volume":"6","author":"LS Mathews","year":"1991","unstructured":"Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell. 1991;6:973\u201382.","journal-title":"Cell"},{"key":"1435_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0092-8674(92)90209-U","volume":"1","author":"L Attisano","year":"1992","unstructured":"Attisano L, Wrana JL, Cheifetz S, Massague J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine\/threonine kinase receptors. Cell. 1992;1:97\u2013108.","journal-title":"Cell"},{"key":"1435_CR21","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1101\/gad.10.15.1880","volume":"15","author":"JC Baker","year":"1996","unstructured":"Baker JC, Harland RM. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 1996;15:1880\u20139.","journal-title":"Genes Dev"},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3748\/wjg.v16.i11.1409","volume":"11","author":"XR Chen","year":"2010","unstructured":"Chen XR, Wang JW, Li X, Zhang H, Ye ZY. Role of BMP3 in progression of gastric carcinoma in Chinese people. World J Gastroenterol. 2010;11:1409\u201313.","journal-title":"World J Gastroenterol"},{"key":"1435_CR23","first-page":"1000145","volume":"145","author":"JB Kisiel","year":"2013","unstructured":"Kisiel JB, Li J, Zou H, Oseini AM, Strauss BB, Gulaid KH, Moser CD, Aderca I, Ahlquist DA, Roberts LR, et al. Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary Cancer. J Mol Biomark Diagn. 2013;145:1000145.","journal-title":"J Mol Biomark Diagn"},{"key":"1435_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.molonc.2010.11.004","volume":"1","author":"JA Ronneberg","year":"2011","unstructured":"Ronneberg JA, Fleischer T, Solvang HK, Nordgard SH, Edvardsen H, Potapenko I, Nebdal D, Daviaud C, Gut I, Bukholm I, et al. Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Mol Oncol. 2011;1:61\u201376.","journal-title":"Mol Oncol"},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/gcc.20552","volume":"6","author":"K Loh","year":"2008","unstructured":"Loh K, Chia JA, Greco S, Cozzi SJ, Buttenshaw RL, Bond CE, Simms LA, Pike T, Young JP, Jass JR, et al. Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer. 2008;6:449\u201360.","journal-title":"Genes Chromosomes Cancer"},{"key":"1435_CR26","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1158\/1055-9965.EPI-07-0518","volume":"12","author":"H Zou","year":"2007","unstructured":"Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev. 2007;12:2686\u201396.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1435_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.rce.2015.08.002","volume":"9","author":"MA Onieva-Garcia","year":"2015","unstructured":"Onieva-Garcia MA, Llanos-Mendez A, Banos-Alvarez E, Isabel-Gomez R. A systematic review of the clinical validity of the Cologuard genetic test for screening colorectal cancer. Rev Clin Esp. 2015;9:527\u201336.","journal-title":"Rev Clin Esp"},{"key":"1435_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1586\/14737159.2015.1069184","volume":"9","author":"JR Ridge","year":"2015","unstructured":"Ridge JR, Statz S. Exact Sciences\u2019 experience with the FDA and CMS parallel review program. Expert Rev Mol Diagn. 2015;9:1117\u201324.","journal-title":"Expert Rev Mol Diagn"},{"key":"1435_CR29","doi-asserted-by":"crossref","first-page":"70214","DOI":"10.18632\/oncotarget.19603","volume":"41","author":"JL Wang","year":"2017","unstructured":"Wang JL, Qi Z, Li YH, Zhao HM, Chen YG, Fu W. TGFbeta induced factor homeobox 1 promotes colorectal cancer development through activating Wnt\/beta-catenin signaling. Oncotarget. 2017;41:70214\u201325.","journal-title":"Oncotarget"},{"key":"1435_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/5047","volume":"1","author":"EE Cameron","year":"1999","unstructured":"Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;1:103\u20137.","journal-title":"Nat Genet"},{"key":"1435_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1128\/MCB.23.1.206-215.2003","volume":"1","author":"Y Kondo","year":"2003","unstructured":"Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol. 2003;1:206\u201315.","journal-title":"Mol Cell Biol"},{"key":"1435_CR32","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"18","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;18:9821\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1435_CR33","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-17-0153","volume":"9","author":"F Niu","year":"2017","unstructured":"Niu F, Wen J, Fu X, Li C, Zhao R, Wu S, Yu H, Liu X, Zhao X, Liu S, et al. Stool DNA test of methylated Syndecan-2 for the early detection of colorectal Neoplasia. Cancer Epidemiol Biomark Prev. 2017;9:1411\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1435_CR34","first-page":"4109","volume":"8","author":"S Naito","year":"1986","unstructured":"Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. Cancer Res. 1986;8:4109\u201315.","journal-title":"Cancer Res"},{"key":"1435_CR35","doi-asserted-by":"publisher","first-page":"jcs213512","DOI":"10.1242\/jcs.213512","volume":"11","author":"OE Olsen","year":"2018","unstructured":"Olsen OE, Sankar M, Elsaadi S, Hella H, Buene G, Darvekar SR, Misund K, Katagiri T, Knaus P, Holien T. BMPR2 inhibits activin and BMP signaling via wild-type ALK2. J Cell Sci. 2018;11:jcs213512.","journal-title":"J Cell Sci"},{"key":"1435_CR36","doi-asserted-by":"publisher","first-page":"e90748","DOI":"10.1371\/journal.pone.0090748","volume":"6","author":"J Hao","year":"2014","unstructured":"Hao J, Lee R, Chang A, Fan J, Labib C, Parsa C, Orlando R, Andresen B, Huang Y. DMH1, a small molecule inhibitor of BMP type i receptors, suppresses growth and invasion of lung cancer. PLoS One. 2014;6:e90748.","journal-title":"PLoS One"},{"key":"1435_CR37","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1016\/j.bmcl.2013.03.113","volume":"11","author":"DW Engers","year":"2013","unstructured":"Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Bioorg Med Chem Lett. 2013;11:3248\u201352.","journal-title":"Bioorg Med Chem Lett"},{"key":"1435_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/85303","volume":"3","author":"BL Kee","year":"2001","unstructured":"Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol. 2001;3:242\u20137.","journal-title":"Nat Immunol"},{"key":"1435_CR39","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1038\/sj.onc.1209407","volume":"26","author":"CM Simbulan-Rosenthal","year":"2006","unstructured":"Simbulan-Rosenthal CM, Daher A, Trabosh V, Chen WC, Gerstel D, Soeda E, Rosenthal DS. Id3 induces a caspase-3- and \u22129-dependent apoptosis and mediates UVB sensitization of HPV16 E6\/7 immortalized human keratinocytes. Oncogene. 2006;26:3649\u201360.","journal-title":"Oncogene"},{"key":"1435_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1078-0432.CCR-15-0726","volume":"22","author":"S Inamoto","year":"2016","unstructured":"Inamoto S, Itatani Y, Yamamoto T, Minamiguchi S, Hirai H, Iwamoto M, et al. Loss of SMAD4 promotes colorectal Cancer progression by accumulation of myeloid-derived suppressor cells through the CCL15-CCR1 chemokine Axis. Clin Cancer Res. 2016;22:492\u2013501.","journal-title":"Clin Cancer Res"},{"key":"1435_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1158\/1078-0432.CCR-15-0726","volume":"2","author":"S Inamoto","year":"2016","unstructured":"Inamoto S, Itatani Y, Yamamoto T, Minamiguchi S, Hirai H, Iwamoto M, Hasegawa S, Taketo MM, Sakai Y, Kawada K. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis. Clin Cancer Res. 2016;2:492\u2013501.","journal-title":"Clin Cancer Res"},{"key":"1435_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13058-017-0857-y","volume":"1","author":"DD Seachrist","year":"2017","unstructured":"Seachrist DD, Sizemore ST, Johnson E, Abdul-Karim FW, Weber Bonk KL, Keri RA. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Breast Cancer Res. 2017;1:66.","journal-title":"Breast Cancer Res"},{"key":"1435_CR43","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s004280050034","volume":"3","author":"IK Bukholm","year":"2000","unstructured":"Bukholm IK, Nesland JM. Protein expression of p53, p21 (WAF1\/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch. 2000;3:224\u20138.","journal-title":"Virchows Arch"},{"key":"1435_CR44","first-page":"381","volume":"2","author":"K Polyak","year":"1996","unstructured":"Polyak K, Hamilton SR, Vogelstein B, Kinzler KW. Early alteration of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathol. 1996;2:381\u20137.","journal-title":"Am J Pathol"},{"key":"1435_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(20000120)89:1<14::AID-IJC3>3.0.CO;2-L","volume":"1","author":"TK Zirbes","year":"2000","unstructured":"Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, Shafizadeh ST, Schneider PM, Thiele J, Hoelscher AH, Dienes HP. Prognostic impact of p21\/waf1\/cip1 in colorectal cancer. Int J Cancer. 2000;1:14\u20138.","journal-title":"Int J Cancer"},{"key":"1435_CR46","first-page":"1421","volume":"65","author":"H Mitomi","year":"2005","unstructured":"Mitomi H, Mori A, Kanazawa H, Nishiyama Y, Ihara A, Otani Y, Sada M, Kobayashi K, Igarashi M. Venous invasion and down-regulation of p21(WAF1\/CIP1) are associated with metastasis in colorectal carcinomas. Hepatogastroenterology. 2005;65:1421\u20136.","journal-title":"Hepatogastroenterology"},{"key":"1435_CR47","doi-asserted-by":"publisher","first-page":"e39381","DOI":"10.1371\/journal.pone.0039381","volume":"6","author":"J Bauer","year":"2012","unstructured":"Bauer J, Sporn JC, Cabral J, Gomez J, Jung B. Effects of activin and TGFbeta on p21 in colon cancer. PLoS One. 2012;6:e39381.","journal-title":"PLoS One"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1435-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T19:56:14Z","timestamp":1721937374000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1435-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1435-1","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"9 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human tissue samples were obtained from the tissue bank of the Sixth Affiliated Hospital, Sun Yat-sen University (Guangzhou, China). Methods were performed in accordance with the guideline approved by the Institutional Review Board at the Sixth Affiliated Hospital of Sun Yat-sen University.Animal experiments were approved by the Ethics Committee of Sun Yat-sen University Health Science Center.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}